GFAP and Alpers syndrome: Finally, it is recognised that anti-GFAP antibodies only label a subset of astrocytes [68], however, the limited tissue availability prevented the inclusion of additional markers to identify individual astrocytes, albeit the majority of Alpers’ syndrome patient astrocytes were GFAP+.